日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells

EGFR抑制剂奥希替尼耐药持续细胞的治疗脆弱性概况

Criscione, Steven W; Martin, Matthew J; Oien, Derek B; Gorthi, Aparna; Miragaia, Ricardo J; Zhang, Jingwen; Chen, Huawei; Karl, Daniel L; Mendler, Kerrin; Markovets, Aleksandra; Gagrica, Sladjana; Delpuech, Oona; Dry, Jonathan R; Grondine, Michael; Hattersley, Maureen M; Urosevic, Jelena; Floc'h, Nicolas; Drew, Lisa; Yao, Yi; Smith, Paul D

Plasmacytoid Dendritic Cell-driven Induction of Treg Is Strain Specific and Correlates With Spontaneous Acceptance of Kidney Allografts

浆细胞样树突状细胞驱动的 Treg 诱导具有菌株特异性,并与肾移植的自发接受相关

Nicholas A Oh, Thomas O'Shea, Dorothy K Ndishabandi, Qing Yuan, Shuahuan Hong, Jared Gans, Jifu Ge, Sean Gibney, Catharine Chase, Chao Yang, Ivy Rosales, Kazunobu Shinoda, Benjamin Drew, Lisa Kojima, Paul S Russell, Joren C Madsen, Robert B Colvin, Alessandro Alessandrini

Multiscale Model Identifies Improved Schedule for Treatment of Acute Myeloid Leukemia In Vitro With the Mcl-1 Inhibitor AZD5991

多尺度模型确定了使用 Mcl-1 抑制剂 AZD5991 体外治疗急性髓系白血病的改进方案

Goliaei, Ardeshir; Woods, Haley A; Tron, Adriana E; Belmonte, Matthew A; Secrist, J Paul; Ferguson, Douglas; Drew, Lisa; Fretland, Adrian J; Aldridge, Bree B; Gibbons, Francis D

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.

利用高通量肿瘤细胞系分析鉴定与基因型相关的对选择性激酶抑制剂的敏感性

McDermott Ultan, Sharma Sreenath V, Dowell Lori, Greninger Patricia, Montagut Clara, Lamb Jennifer, Archibald Heidi, Raudales Raul, Tam Angela, Lee Diana, Rothenberg S Michael, Supko Jeffrey G, Sordella Raffaella, Ulkus Lindsey E, Iafrate A John, Maheswaran Shyamala, Njauw Ching Ni, Tsao Hensin, Drew Lisa, Hanke Jeff H, Ma Xiao-Jun, Erlander Mark G, Gray Nathanael S, Haber Daniel A, Settleman Jeffrey